TO ALL ENLISTED: GET REELIN IV, PROTEIN INFUSION THERAPIES SET UP, EVERY DAY, FOR ALL ENLISTED:

https://medicalxpress.com/news/2018-07-link-brain-protein-depression-treatments.html

THIS WILL PREVENT SUICIDE RATES DURING THE FEDERAL GOVERNMENT SHUTDOWN.

https://www.businessinsider.com/most-promising-new-depression-drugs-treatments-predictions-2019-2018-12

ALSO, GET EVERYONE OVER AGE 7 ONTO ABILIFY MAINTENA, IMMEDIATELY.

https://psychnews.psychiatryonline.org/doi/full/10.1176/appi.pn.2018.pp9a1

DURING PREGNANCY, ONLY RECOMMEND A PRENATAL MULTIVITAMIN.

https://medicalxpress.com/news/2019-01-insufficient-evidence-antidepressants-affect-fertility.html

...BUT, RIGHT AFTER GIVING BIRTH, DO NOT ALLOW BREASTFEEDING.

https://www.fda.gov/Drugs/DrugSafety/ucm498662.htm

GET THE INFANTS ONTO PRETERM INFANT FORMULA, PREFERABLY ENFAMIL, FOR PREMATURE NEWBORNS.

https://psychcentral.com/lib/what-you-need-to-know-about-the-newest-antidepressants/

THEN, GET THE MUMS ONTO THE HIGHEST DOSE ALLOWABLE OF ABILIFY MAINTENA, EVERY THREE WEEKS, ADMINISTERED FOR TEN YEARS, MINIMALLY, TO PREVENT THE HIGH CANCER RATES ASSOCIATED WITH PREGNANCY.

https://www.psychcongress.com/article/new-generation-depression-treatment-approaches

ONCE THEIR CHILD TURN INTO ADOLESCENT, MAKE THEM GET ONTO THE HIGHEST DOSE ALLOWABLE OF ABILIFY MAINTENA, EVERY THREE WEEKS, AS THE CHILDREN, IN GENERAL, ARE NEVER KNOWN TO BE CAPABLE OF BEHAVING THEMSELVES.

https://medicalxpress.com/news/2019-01-insufficient-evidence-antidepressants-affect-fertility.html

http://www.psychiatrictimes.com/depression/choosing-right-antidepressant

https://womensmentalhealth.org/posts/brexanolone_new_drug_postpartum_depression/

ALSO, TITRATE ALL ANXIETY, DEPRESSION, BATTERED, TRAUMATIZED, I.B.S., AND G.I. TRACT PATIENTS, OVER AGE 12, ONTO VILAZODONE 40 MG/D, IN A THREE MONTH PERIOD:

https://www.mdedge.com/psychiatry/article/96727/depression/prescribers-guide-using-3-new-antidepressants-vilazodone

ONCE PER WEEK, EVERY WEEK, ATTEMPT A FREE BREXANOLONE OR GANAXOLONE IV INFUSION, EACH IN A SIXTY HOUR IV SESSION, ON POSTPARTUM DEPRESSION PATIENTS, FOR TWELVE MONTHS, SO BOOK THEM INTO A FREE PSYCHIATRIC HOSPITAL FOR FOUR DAYS PER WEEK, EVERY WEEK, UNTIL THEIR MADRS SCORE IMPROVES:

MADRS SCORE:

https://psychology-tools.com/test/montgomery-asberg-depression-rating-scale

https://psychnews.psychiatryonline.org/doi/full/10.1176/appi.pn.2018.pp9a1

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31551-4/fulltext

https://www.psychcongress.com/news/brexanolone-infusion-rapidly-relieves-postpartum-depression

https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM624646.pdf&ved=2ahUKEwiTzsS87ofgAhXij4MKHYDtAjAQFjADegQIBxAB&usg=AOvVaw2dq7vu7cxAKVGbwJokMeIu

https://psychnews.psychiatryonline.org/doi/full/10.1176/appi.pn.2018.pp10a2

https://www.medpagetoday.com/meetingcoverage/apa/72758

https://www.mdedge.com/psychiatry/article/177197/depression/brexanolone-injection-quickly-improves-postpartum-depression

https://www.mdmag.com/medical-news/brexanolone-reports-rapid-durable-treatment-for-postpartum-depression

http://fortune.com/2018/11/02/fda-poised-to-approve-zulresso-brexanolone-postpartum-depression-drug/

https://clinicaltrials.gov/ct2/show/NCT03665038

GANAXOLONE:

https://www.ptcommunity.com/wire/marinus-pharmaceuticals-announces-positive-ganaxolone-data-women-postpartum-depression

https://www.marinuspharma.com

https://globenewswire.com/news-release/2018/12/10/1664282/0/en/Marinus-Pharmaceuticals-Announces-Positive-Ganaxolone-Data-in-Women-With-Postpartum-Depression.html

https://www.smartpatients.com/trials/NCT03228394

https://seekingalpha.com/news/3415555-marinus-pharmas-ganaxolone-shows-positive-action-mid-stage-postpartum-depression-studies

https://clinicaltrials.gov/ct2/show/NCT03460756

https://www.centerwatch.com/clinical-trials/listings/122963/depression-clinical-trial-intravenous-ganaxolone/

https://xconomy.com/boston/2018/12/10/marinus-claims-phase-2-postpartum-depression-win-analysts-less-sure/

https://recruit.cumc.columbia.edu/clinical_trial/1274